From: Aspiration therapy for obesity; a safe and effective treatment
Comorbidities under treatment Number of subjects | Baseline, all subjects n = 25 | Baseline, per protocol n = 20 | 12 months, per protocol n = 20 |
---|---|---|---|
Diabetes mellitus type 2 (total) | 7 | 7 | 5 |
- Diet treatment | 2 | 2 | 2 |
- Metformin | 4 | 4 | 2 |
- Metformin + insulin | 1 | 1 | 1 |
Hypertension (total) | 9 | 8 | 7 |
- Diuretic | 6 | 5 | 4 |
- ACE-inhibitor | 5 | 5 | 4 |
- Beta receptor antagonist | 3 | 3 | 3 |
Hyperlipidemia (total) | 2 | 2 | 2 |
- Statin | 2 | 2 | 2 |
Mood disorder (total) | 9 | 6 | 6 |
- SSRI | 8 | 6 | 6 |
- Tricyclic antidepressant | 1 | 0 | 0 |
Gastroesophageal reflux disease | 2 | 2 | 3 |
- Omeprazole | 2 | 2 | 3 |